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such as cytochrome P450 become apparent only under patho-Heme oxygenase isoform-specific expression and distribution
physiological conditions causing HO induction.in the rat kidney.
Background. The heme oxygenase (HO) genes, HO-1 and
HO-2, are the limiting steps in heme degradation and in the
regulation of renal heme-dependent enzymes. Previously we Significant and mounting evidence indicates a closereported that selective overexpression of renal HO-1 resulted
relationship between heme metabolism, kidney function,in a decrease of microsomal heme and the cytochrome P450-
and blood pressure regulation. Heme functions as thedependent arachidonic acid metabolite, 20 HETE, a vasocon-
strictor. The present study was undertaken to explore the rela- prosthetic moiety for a number of heme-containing pro-
tive expression and contribution of each of the HO isoforms teins with activities that are critical to vascular and renal
to HO activity in the rat kidney. function. These include soluble guanylate cyclase, nitricMethods and Results. Renal HO activity increased above
oxide synthase (NOS), and enzymes of the eicosanoidcontrol levels after an injection of the inducers of HO activity,
biosynthetic pathways, including cytochrome (CYP) P-450heme or SnCl2. Stannous Mesoporphyrin (SnMP), a nonselec-
tive inhibitor of HO, when used alone or in combination with mono-oxygenases, thromboxane and prostacyclin syn-
heme or SnCl2, decreased HO activity. Heme alone and com- thases, and the heme-dependent cyclooxygenase. Heme
bined with SnCl2 decreased the levels of heme content by 13 oxygenase (HO), as the key enzyme in heme degrada-
and 35%, respectively. Western blot analysis showed that both
tion, not only controls cellular levels of heme availableSnCl2 and heme readily induced HO-1 protein, whereas HO-2
for the synthesis of heme proteins but is also responsiblewas constitutively expressed. Immunohistochemistry showed
for the generation of the vasodepressor gas, carbon mon-the distribution of the HO-1 isoform primarily in proximal
convoluted tubules. Western blot analysis exhibited relatively oxide (CO), which by itself can bind to the heme moiety
higher levels of HO-1 in isolated proximal tubules and rela- of these heme proteins, causing either enzyme activation
tively higher HO-2 levels in the thick ascending limbs of the or inhibition [1–3].loop of Henle and preglomerular arterioles. In vivo administra-
The importance of HO thus resides in degrading hemetion of HO-1 and HO-2 antisense oligodeoxynucleotides fur-
and regulating the activity of heme proteins. To date,ther confirmed that HO-2, but not HO-1, contributed to the
basal HO activity; however, following induction of HO with three isoforms that are the products of three distinct
heme, antisense to HO-1, but not to HO-2, inhibited the in- genes have been identified. HO-2 is constitutively ex-
duced levels of HO activity. pressed and localized primarily in the brain, testis, and
Conclusion. These results suggest that HO-2 is constitutively
the vasculature [4, 5]. The newly described HO-3 exhibitsexpressed in the rat kidney mainly within tubular and arteriolar
90% homology to HO-2, and its mRNA has been de-structures, and its activity may modulate physiological function
under basal conditions. On the other hand, the basal levels of tected in many tissues, including the kidney [6]; however,
expression of HO-1 in the rat kidney are relatively low, and its it lacks significant catalytic activity and may only function
contribution to HO activity and the regulation of hemoproteins as a heme-regulatory protein through its capacity to bind
heme [6]. HO-1 is an inducible isoform with widespread
tissue distribution, including the liver, kidney, and lung.Key words: blood pressure, hypertension, vasoconstriction, cellular
Induction of HO-1 by heavy metals such as SnCl2 orheme, carbon monoxide, kidney function, eicosanoid regulation, HO-1
and HO-2 genes. heme analogues results in a prominent increase in HO
activity followed by a depletion of several hemoproteins,Received for publication March 1, 2000
including CYP450 [7, 8]. Previous studies demonstratedand in revised form September 22, 2000
Accepted for publication October 30, 2000 that administration of SnCl2 or heme to young spontane-
ously hypertensive rats (SHRs) caused a significant in-Ó 2001 by the International Society of Nephrology
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crease of renal HO expression and activity. This effect catheter placed into the femoral vein for oligodeoxy-
was associated with a selective decrease in renal CYP450- nucleotide (ODN) administration. The rats were allowed
arachidonic acid (AA) metabolism and a concomitant 24 hours to recover before commencing treatment. Lipo-
reduction in blood pressure, suggesting a prohyperten- some-encapsulated antisense ODNs, sense ODNs, or
sive role for the CYP-AA [9]. Heme arginate, a HO scrambled ODNs were injected daily as bolus at doses
inducer, caused a similar reduction in blood pressure of 200 mg/100 g body weight/day for five days. Additional
in the young SHR. Pretreatment with the potent HO rats were treated with liposomes (200 mg/100 g body
inhibitor zinc 2,4-deuteroprotoporphrin-X-bisglycol at- weight/day) mixed with the ODN vehicle (water). In
tenuated the reduction in blood pressure seen with the some experiments, heme (1.5 mg/100 g body weight)
heme arginate [10]. These results and those of others was administered subcutaneously on day 5 of the ODN
[11, 12] clearly indicate that there is an intimate relation- treatment. On day 6 after the onset of treatment, the
ship between heme metabolism and blood pressure regu- rats were sacrificed, and tissues (liver and kidney) were
lation. removed for extraction of RNA and preparation of mi-
Increasing evidence indicates that CO arising from crosomes as described previously in this article. The fol-
heme via metabolism by HO exerts a vasodilatory effect lowing ODN preparations were used: HO-1 antisense
and that inhibition of HO causes vascular constriction in (HO-1-AS; 10 to 29), 59-GGCGCTCCATCGCGGG
numerous vascular beds [13–17]. These findings broaden CTG-39; HO-1 sense (HO-1-S; 29 to 6), 59-CAGCCCG
the already important role of the heme-HO system as a CGATGGAGCGCC-39; HO-2 antisense (HO-2-AS; 11
regulatory system in the kidney. Recent reports indicat- to 29), 59-TCTGAAGACATTGTTGCTGA-39; HO-2
ing that CO generated by HO-dependent heme catabo- sense (HO-2-S; 29 to 11), 59-TCAGCAACAATGTCT
lism stimulates the apical 70-pS K-channel of the thick TCAGA-39. A similar strategy in the use of HO-1 and
ascending limb of the loop of Henle in the rat (TAL) HO-2 ODN preparations has been shown to be efficacious
further underscore the potential importance of HO to in modulating HO activity in cultured endothelial cells
the regulation of kidney function [18]. [19]. Cationic liposomes composed of dimethyldioctade-
Renal HO activity arises primarily from two different cylammonium bromide (DDAB) and L-a-dioleylphos-
isoforms, HO-1 and HO-2, and their role in renal func- phatidylethanolamine (DOPE; 2:5, wt/wt) were prepared
tion has not been adequately addressed. As part of our according to the manufacturer instructions (Avanti Polar
ongoing studies aimed at defining the mechanisms in- Lipid Inc., Alabaster, AL, USA).
volved in the role of heme catabolism in kidney function
and blood pressure regulation, we undertook the present Preparation of renal microsomes
study. Herein, we explore the expression and the poten-
Kidneys were immediately perfused with cold sa-tial contribution of each of the two major active HO
line, sliced, and homogenized (4 mL/g wet weight) inisoforms, HO-1 and HO-2, to renal heme metabolism.
10 mmol/L Tris buffer, pH 7.5, containing 0.25 mol/L
sucrose. The tissue homogenates were centrifuged at
METHODS 27,000 3 g for 20 minutes at 48C. The supernatant was
centrifuged at 105,000 3 g for one hour at 48C, and theAnimal treatment
resulting microsomal pellet was resuspended in 0.1 mol/LMale Sprague-Dawley rats (Harlan, 7 weeks old) were
potassium phosphate buffer, pH 7.6. The protein concen-housed for four to five days before the beginning of
tration was determined according to the method of Brad-the study. SnCl2 (10 mg/100 g body weight), heme (1 mg/
ford (Bio-Rad, Hercules, CA, USA).100 g body weight), or Stannous Mesoporphyrin (SnMP;
5 mmol/100 g body weight) was administered subcutane- Isolation of renal microvessels, proximal tubules, and
ously. Control rats were injected with saline. Control TAL segments
and treated rats were killed after 24 hours. One kidney
Isolation of the microvessels was performed using Ev-from each rat was immediately frozen in liquid nitrogen
ans Blue and sequential sieving of minced cortex [20].for RNA extraction. The other kidney was used for en-
This preparation contains more than 90% pure microves-zyme measurement of HO activities and heme content.
sels, including afferent and interlobular arterioles, as evi-When kidneys were processed for isolation of microves-
denced by phase contrast microscopy and by the absencesels and tubules, both kidneys were used, and fractions
of immunoreactive g-glutamyl transpeptidase (g-GT), aof the isolated structures were immediately frozen for
specific marker for the proximal tubule brush borderRNA extraction.
[21, 22]. The yield from one rat (two kidneys) was ap-
Treatment with HO-1 and HO-2 proximately 5 to 6 mg of total RNA and 200 to 300 mg
antisense oligodeoxynucleotides of protein. Proximal tubules were isolated by Percoll
gradient separation [23], and their purity was assessedRats anesthetized with sodium phenobarbital (60 mg/kg,
IP) were instrumented with a polyethylene (PE 5 50) by alkaline phosphatase staining (Sigma Diagnostics Al-
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kaline Phosphatase Kit; Sigma, St. Louis, MO, USA) and probe used for rat HO-1 was the 833 bp EcoRI/HindIII
fragment prepared in the pRHO-1 vector, a plasmid con-by the presence of immunoreactive g-GT. This method
yields approximately 6 to 8 mg of microsomal protein taining full-length cDNA for HO-1 [27]. The probe for
rat HO-2 (624 bp) was generated by reverse transcriptase-from one rat (2 kidneys). Thick ascending loop of Henle
segments were isolated from the inner strip of the outer polymerase chain reaction (RT-PCR) from rat testis total
RNA using the following primers: 59-TTCAGAGGTGmedulla using an enzymatic digestion followed by a siev-
ing technique as described by Ito et al [20]. GAGACCTCGGAG-39 and 59-CAGGTCCAAGG-CA
TTCATCCTG-39 as described previously [28]. Autora-
Measurement of HO activity diography was performed for varying lengths of time at
2808C using XAR-5 film (Eastman Kodak Co., Roches-Microsomal HO activity was assayed by the method
of Abraham et al in which bilirubin, the product of HO ter, NY, USA) with Lighting-Plus intensifying screens
(DuPont Co., Wilmington, DE, USA). The relativedegradation, was extracted with chloroform, and its con-
centration was determined spectrophotometrically (model amounts of HO-1 and HO-2 mRNA were determined
by scanning the blots using National Institutes of HealthDW-2C; Aminco, Urbana, IL, USA) using the difference
in absorbance at wavelength at l from 460 and l 530 nm Image software program. The density of GAPDH mRNA
was used for normalization of the data.with an absorption coefficient of 40 mmol/L21 and cm21
[8, 24].
Western blot analysis of HO-1 and HO-2
Microsomal heme determination Whole kidney microsomes or cell-free homogenates
(10,000 3 g supernatant) of proximal tubules, TALH, andMicrosomal heme was determined as the pyridine
hemochromogen by using the reduced minus oxidized renal microvessels (10 to 50 mg protein) were separated
by sodium dodecyl sulfate-polyacrylamide gel electro-difference in absorbance at l 400 and l 600 nm with an
absorption coefficient of 32.4 mmol/L21 cm21 [24]. phoresis (SDS-PAGE) and transferred to a nitrocellu-
lose membrane using a semidry transfer apparatus (Bio-
CYP450 content Rad). The membranes were incubated with 5% milk in
10 mmol/L Tris-HCl, pH 7.4, 150 mmol/L NaCl, and 0.05%Microsomal CYP450 content was measured as pre-
viously described [25]. Briefly, renal microsomes were Tween 20 (TBST) buffer at 48C overnight. After washing
with TBST, the membranes were incubated with a 1:2000prepared, and protein concentration was determined as
described previously in this article. CYP450 content was dilution of anti–HO-1 or anti–HO-2 antibodies (Stressgen
Biotechnologies Corp., Victoria, British Columbia, Can-measured from the reduced CO difference spectrum using
sodium dithionite as the reducing agent. The absorbance ada) for one hour at room temperature with constant
shaking. Then the filters were washed and subsequentlydifference at wavelength l 450 and l 490 nm was moni-
tored, and the CYP450 content was calculated using a probed with horseradish peroxidase-conjugated donkey
anti-rabbit IgG (Amersham, Arlington Heights, IL, USA)molar extinction coefficient of 91 mmol/L21 cm21 [26].
at a dilution of 1:2000. Chemiluminescence detection
Arachidonic acid metabolism was performed with the Amersham ECL detection kit
according to the manufacturer’s instructions.Renal microsomes (50 mg protein) or microvessel
homogenates (100 mg protein) were preincubated with
Immunohistochemistry[1-14C]-AA (0.4 mCi, 7 nmol) in 100 mmol/L potassium
phosphate buffer, pH 7.4, containing 10 mmol/L MgCl2 Tissues were fixed by immersion in formalin and em-
bedded in paraffin. Two to four micron thick microtomefor three minutes at 378C. Nicotinamide adenine dinucle-
otide phosphate (NADPH; 1 mmol/L) was added, and sections were prepared. Following deparaffinization in
xylene and rehydration through graded ethanol and wa-the reaction mixture (final volume of 0.3 mL) was incu-
bated for 30 minutes at 378C. Radiolabeled metabolites ter, the slides were washed with phosphate-buffered sa-
line (PBS), and the endogenous peroxidase was inhibitedwere separated by reverse phase–high-pressure liquid
chromatography (RP-HPLC) and the rate of synthesis by incubating the slides for 15 minutes with 3% H2O2.
The nonspecific protein binding sites were blocked withof 19/20-HETE estimated as previously described [25].
10% horse serum (ABC kit Vectastain; Vector Lab, Inc.,
Northern blot analysis for HO-1 and HO-2 Burlingame, CA, USA) for 20 minutes, followed by the
addition of antisera against HO-1 at a dilution of 1:200Total RNA was extracted from rat kidneys by the sin-
gle-step method using guanidinium thiocyanate-phenol- and overnight incubation at 48C in a moist chamber.
After this incubation, the slides were washed in PBS andchloroform and sodium acetate. Ten micrograms of total
RNA were electrophoresed on gels containing 1% aga- incubated with the second biotinylated antibody at a
dilution of 1:1000 for 30 minutes at room temperature.rose and 1 mol/L formaldehyde, transferred to a nylon
membrane, and hybridized with 32P-labeled probes. The The slides were washed in PBS, and the ABC solution
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(ABC kit Vectastain) was applied for 30 minutes at room
temperature. The staining solution was prepared using
Sigma fast 3,3-diaminobenzidine tablets (Sigma) and ap-
plied on the slides for two minutes. Then the slides were
counterstained with hematoxylin and mounted under
coverslips.
Statistical analysis
The results are presented as mean 6 SE for the num-
ber (N) of replicate determinations. Statistical signifi-
cance of differences between the experimental groups
was estimated by using analysis of variance and Student
t test, with P , 0.05 considered significant.
RESULTS
HO isoform expression in rat kidney in response to
SnCl2 and heme
We examined the effect of SnCl2 and heme on levels
of HO-1 and HO-2 protein and mRNA in rat kidney.
Western blot of whole kidney microsomes indicated low
basal levels of HO-1 protein (Fig. 1A, lane 1) that were
markedly increased following treatment with heme and
SnCl2 (Fig. 1A, lanes 2 and 3, respectively). In contrast,
significant levels of HO-2 were detected in untreated
control microsomes (Fig. 1A, lane 1). Unlike HO-1, HO-2
protein levels did not increase in microsomes from SnCl2-
treated rats (Fig. 1A, lane 2). However, heme treatment
did cause a significant increase in HO-2 protein (Fig.
1A, lane 3). Parallel determinations of mRNA levels
by Northern analysis of total RNA from whole kidney
indicated similar patterns of HO-1 and HO-2 expression.
As seen in Figure 1B, the levels of HO-1 mRNA were
increased after six hours of treatment by both heme and
SnCl2 (lanes 2 and 3, respectively). Levels of HO-2 were
essentially unchanged.
HO activity in rat kidney in response to SnCl2 and heme
The increase in microsomal HO activity in response
to SnCl2 treatment was of greater magnitude than in
response to heme treatment from 0.75 nmol to 1.5 and
3.8 nmol bilirubin/mg/30 min in heme versus SnCl2-
b
Fig. 1. Effect of heme and SnCl2 on heme oxygenase isoforms 1 and 2
[( ) HO-1 and (j) HO-2] mRNA and protein levels in the rat kidney.
(A) Western blot and densitometry analyses of HO-1 and HO-2 protein
levels in renal microsomes from control and rats treated with SnCl2
(10 mg/100 g body weight) or heme (1 mg/kg body weight). Renal
microsomes were prepared 24 hours later and subjected to electrophore-
sis and immunoblotting. Lane 1, control; lane 2, heme; lane 3, SnCl2; lane
4, positive controls (SnMP-treated kidney for HO-1). Testis microsomes
were used for HO-2. (B) Northern analysis of total kidney RNA isolated
eight hours after injection of SnCl2, heme, or the vehicle control using
specific HO-1, HO-2, and GAPDH cDNA labeled probes as described
in the Methods section.
da Silva et al: Expression of HO isoforms1452
Fig. 2. Effect of heme and SnCl2 on renal microsomal HO activity (A) and heme content (B). HO activity was determined as nmol bilirubin
formed/mg/30 min and heme content as percentage from control. Results are mean 6 SE, N 5 4. *, **, #P , 0.05 as compared to control.
treated rats (Fig. 2A). The increase in HO activity was Interestingly, the administration of SnMP resulted in a
decrease in HO-2 protein levels. (Fig. 2C, lanes 4, 5,inhibited by simultaneous administration of the HO in-
hibitor SnMP. When SnMP was used alone or in combi- and 6, respectively). The mechanism by which SnMP
decreases HO-2 protein is currently under investigation.nation with heme or SnCl2, the activity markedly de-
creased in all treatments (Fig. 2A).
Localization of HO protein in the rat kidneyAlong with HO activity, we measured the heme con-
tent after treatment with SnCl2 or heme (Fig. 2B). As The specific localization of HO isoforms within the
expected, both heme and SnCl2 decreased the levels of kidney may have important implications with regard to
heme by 13 6 7% and 35 6 4%, respectively. SnMP, an renal vascular and tubular function. Immunohistochemi-
inhibitor of HO activity, reversed the decline in cellular cal localization using antibodies against HO-1 showed
heme seen in rats pretreated with SnCl2 and heme. Heme predominant staining in proximal and distal tubules in
levels increased when heme or SnCl2 were combined the cortex (Fig. 3A). In the medulla, HO-1 immunolocal-
with SnMP. ized mainly in medullary collecting tubules and loops of
The effect of heme and SnCl2 treatment on HO-1 Henle (Fig. 3B). Immunohistochemistry studies using
and HO-2 protein levels in the presence and absence of antibodies against HO-2 showed similar patterns of ex-
SnMP was assessed by Western blot analysis. Rats were pression, albeit the signal/staining was very weak (data
pretreated with SnMP followed by injection of SnCl2 or not shown), indicating that these antibodies may not be
heme for 24 hours. Western blot analysis revealed that efficient for immunohistochemical analysis.
the rat kidney contained low basal levels of HO-1 protein We further evaluated the basal and the induced HO-1
(Fig. 2C, lane 1). The administration of either heme or and HO-2 protein levels by Western analysis in homoge-
SnCl2 resulted in enhancement of HO-1 protein (Fig. nates of three different renal structures: proximal tubules,
2C, lanes 2 and 3, respectively). The combined treatment TAL, and preglomerular arterioles. A representative ex-
of heme or SnCl2 with SnMP further enhanced HO-1 periment is shown in Figure 4A. TAL and arterioles
protein levels (Fig. 2C, lanes 5 and 6 compared with expressed low levels of HO-1 protein (lanes 2 and 3,
lanes 2 and 3, respectively). Treatment with SnMP alone respectively) relative to those in proximal tubules in
increased HO-1 protein levels (Fig. 2C, lane 4 compared which the highest levels of HO-1 were detected (lane 1).
with lane 1). Although SnMP is an inhibitor of both HO-1 Western blot analysis of HO-2 protein showed a different
and HO-2 activity, it also acts as an activator of HO-1 pattern of expression; arteriolar homogenates expressed
high levels of HO-2 (Fig. 4A, lane 3), followed by TALgene expression, thereby increasing HO-1 protein levels.
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Fig. 3. Immunohistochemical localization of HO-1 in the kidney.
Arrows point to proximal tubules staining positive for HO-1. Glomeruli
and distal tubules stained negative.
Fig. 4. (A) Western blot analysis of HO-1 and HO-2 in rat renal tissues.
Microsomes were prepared from (lane 1) proximal tubules; (lane 2)(lane 2) and proximal tubules, which demonstrated the
thick ascending limb of Henle (TALH); (lane 3) renal microvessels;
lowest levels (lane 1). The administration of heme pri- and (lane 4) positive controls (SnMP-treated kidney for HO-1). (Lane
4) Testis microsomes as a positive control for HO-2. (B) Western blotmarily enhanced the levels of HO-1 protein in any given
analysis of HO-1 and HO-2 in preglomerular arterioles from control,kidney structure with little effect on HO-2 protein levels. heme, and SnCl2-treated rats.
As seen in Figure 4B, SnCl2 treatment increased HO-1
in arterioles without affecting the levels of HO-2 protein.
Heme administration also increased the levels of HO-1,
(Fig. 5B) showed a decrease in the HO-1 immunoreac-albeit to levels significantly lower than SnCl2 (Fig. 4B).
tive signal in microsomes obtained from rats treated withSimilar changes in HO-1 protein levels were seen in
HO-1 antisense ODN (lane 3) when compared withproximal tubules and TAL from SnCl2 and heme treated
heme-treated rats (lane 2). HO-2 antisense or senserats (data not shown).
ODN did not change HO-1 protein levels (lanes 4 and
Effect of in vivo HO-1 and HO-2 antisense 6, compared with lane 2).Western analysis with HO-2
oligodeoxynucleotide administration on antibodies showed a decrease in HO-2 protein levels
HO protein and activity following treatment with HO-2 antisense ODN (lane 4
compared with lane 2). Treatment with HO-2 senseTo explore further the relative contribution of HO-1
ODN had no effect on the HO-1 protein level (lane 6and HO-2 to renal cellular heme and heme dependent
compared with lanes 1 and 2). Similarly, pretreatmentenzyme activity, we used antisense ODNs as isoform-
with HO-1 sense ODN did not modulate HO-1 or HO-2specific inhibitors [19]. Rats were administered liposome-
protein levels (lane 5 compared with lane 2).encapsulated phosphorothionate-modified sense and anti-
Parallel studies on changes in HO activity in ratssense ODNs of HO-1 or HO-2 mixtures using a protocol
treated with HO antisense ODNs without heme adminis-similar to that described by Wang et al [21]. Two groups
tration (controls) showed different effects. As seen inserved as positive controls; one group received saline
Figure 6A, basal HO activity in renal microsomes didthroughout the experiment, and the other group also
not change following HO-1 antisense ODN treatment.received saline with addition of heme at day 4 of the
However, HO-2 antisense ODN significantly (P , 0.01)treatment. Two experimental groups received liposome-
inhibited the basal HO activity. The specificity of theencapsulated antisense or sense with and without heme
HO antisense ODNs was further verified by Westernon day 4 of the treatment. As seen in Figure 5A, treat-
blot analysis. As seen in Figure 6B, HO-2 protein levelsment with HO-1 antisense ODN inhibited HO activity
were markedly reduced in renal microsomes from HO-2by 50% (P , 0.05) in the heme-treated rat. In contrast,
antisense treated rats (lane 4 compared with lane 1).treatment with HO-2 antisense ODN decreased heme-
HO-2 levels were unchanged in renal microsomes ob-induced HO activity by 30%. The administration of HO-2
tained from rats treated with HO-2 sense ODN (lane 5sense ODN under the same conditions had no effect on
heme-induced HO activity (Fig. 5A). Western analysis compared with lane 1) or from rats treated with HO-1
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Fig. 5. Effect of in vivo administration of HO-1 and HO-2 antisense
oligonucleotides (ODNs) on heme-pretreated rats. (A) HO activity. (B)
HO-1 and HO-2 protein levels. Control, lane 1; heme, lane 2; HO-1
antisense ODNs, lane 3; HO-2 antisense ODNs, lane 4; HO-1 sense
ODN, lane 5; and HO-2 sense ODNs, lane 6. HO activity and protein
levels were measured in whole kidney microsomes as described in the Fig. 6. Effect of in vivo administration of HO-1 antisense oligonucleo-
Methods section. Results are expressed as the mean 6 SEM of three tides (ODNs) on rat kidney. (A) HO activity. (B) HO-1 and HO-2
different rats. HO activity were determined in triplicate for each rat. protein levels. Control, lane 1; HO-1 antisense ODNs, lane 2; HO-1
N 5 3 rats per group. *P , 0.05 compared with control; **P , 0.05 sense ODNs, lane 3; HO-2 antisense ODNs, lane 4; and HO-2 sense
compared with control from heme alone. ODNs, lane 5. HO activity and protein levels were measured in whole
kidney microsomes as described in the Methods section. Results are
expressed as the mean 6 SEM of three different rats. HO activity and
heme content were determined in triplicate for each rat. *P , 0.05
compared with control or sense ODN-treated rats.antisense ODN (lane 2) or sense ODN (lane 3). The
specificity of HO-1 antisense on the basal levels of HO-1
protein was not clearly documented because of the low
levels of HO-1 in uninduced rats (Fig. 6B). administration of heme and SnCl2 were combined with
SnMP, an inhibitor of HO activity, CYP450 was main-
Effect of HO modulation on CYP450 content and activity tained at level of 27 and 42% higher than the levels of
Previous studies have shown a reciprocal relationship CYP450 seen by injection of heme and SnCl2 alone,
between HO and CYP and have suggested HO as a respectively (Fig. 7A). CYP450-AA v-hydroxylase activ-
major regulatory pathway for the production of CYP450- ity measured as 20-HETE synthesis was reduced after
derived eicosanoids, primarily 20-hydroxyeicosatetra- SnCl2 or heme administration by 45 and 30%, respec-
noic acid (20-HETE). Results depicted in Figure 7 con- tively (P , 0.05).
cur with previous observations and further show that We finally examined whether elevation of HO-1 pro-
changes in HO activity were accompanied by changes tein in renal microvessels modulates CYP450-mediated
in CYP450 content (Fig. 7A) and CYP-AA metabolism 20-HETE production. As seen in Figure 8, production
(Fig. 7B). A significant decrease in microsomal CYP450 of 20-HETE by renal microvessels from rats that had
content was also observed 24 hours after a single injec- received SnCl2 for 24 hours was decreased by 40%. Pre-
tion of heme or SnCl2 (0.17 6 0.01 and 0.11 6 0.02 administration of the HO inhibitor chromium meso-
nmol for heme and SnCl2, respectively, as compared with porphyrin (similar to SnMP in specificity) reversed the
SnCl2-mediated decrease of 20-HETE synthesis.control levels of 0.25 6 0.023 nmol; Fig. 7A). When
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Fig. 8. CYP450-AA metabolism to 20-HETE was measured by incuba-
tion of renal microvessels with [14C]-AA and NADPH as described in
the Methods section. Results are the mean 6 SE, N 5 3; *P , 0.05
compared with control; **P , 0.05 compared with SnCl2 alone.
indicate that heme and heavy metals primarily induce
expression of HO-1 and that enhanced HO activity and
events associated with this increase can be mainly attrib-
uted to the increased expression of that specific isoform.
On the other hand, the results also indicate that the basal
level of HO activity within the kidney predominantly
arises from HO-2. These conclusions are derived from
studies with chemical inducers and isoform specific anti-
sense ODNs in the whole animal.
The administration of heavy metals such as SnCl2 or
heme significantly increased levels of HO-1, which is
expressed in relatively low basal levels throughout the
kidney and predominantly in the arteriolar and tubular
components. SnCl2 did not change the expression of
HO-2 in any given renal preparation. The substrate heme
primarily increased HO-1 protein levels and had a lesser
effect on HO-2 expression. Although a detailed quantita-
tive comparison between HO-1 and HO-2 mRNA and
protein levels was not performed, it can be concluded
from Figures 1, 4B, 5, and 6 that HO-2 levels are the
major determinant of the basal heme metabolism in the
kidney. This is based on our studies with antisense
ODNs. The results show that the administration of an
antisense ODNs targeted against HO-2 not only reduced
HO-2 protein expression specifically, but also signifi-
Fig. 7. Renal microsomal P450 content (A) and cytochrome-arachi- cantly decreased renal HO activity. This finding suggestsdonic acid (CYP-AA) v-hydroxylation (B) after treatment with SnCl2
that the basal HO activity in the kidney is driven byor heme. Results are the means 6 SEM, N 5 3. *P , 0.05, significance
from control levels. HO-2 protein, and further indicates that HO-2 protein
levels are relatively higher than HO-1 under basal condi-
tions. This is not the case when chemical inducers are
administered or under pathological conditions that affect
DISCUSSION the expression of the inducible HO isoform. Under such
The present study explores the compartmentalization conditions, the rapid and marked increase of HO-1 ex-
and potential function of the two major HO isoforms, pression yields a large amount of HO-1 protein, which
takes over in terms of HO activity [8, 29–32].HO-1 and HO-2, in the rat kidney. The results clearly
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The distinct localization of HO isoforms within the the studies by Hu et al demonstrating a high level of
kidney may have important functional implications. The expression of HO-2 in the TAL segment [39] suggest
immunohistochemical localization performed with anti- that HO-2 is the source of CO that participates in the
bodies against HO-1 indicates mainly tubular and arteri- regulation of ion transport in this segment.
olar expression. In the cortex, HO-1 immunostaining In various forms of renal parenchymal injury, HO-1
was present in proximal and distal tubules (Fig. 3A). In is highly induced. Two such forms are ischemia/reperfu-
the medulla, HO-1 staining was evident in collecting sion of the kidney and glomerulonephritis. In both condi-
tubules and loop of Henle (Fig. 3B). Recent studies dem- tions, HO-1 expression is increased. Superinduction of
onstrated expression of HO-1 at the mRNA and protein HO-1, prior to onset of ischemia/reperfusion using a
levels in isolated glomeruli and in mesangial cells [33, 34]. spintrap agent, attenuated the extent of tubular injury
Western blot analysis of three different renal structures [40]. Superinduction of HO-1 prior to onset of glomeru-
revealed interesting differences in isoform-specific pat- lonephritis using the specific HO-1 inducer heme attenu-
terns of expression. HO-2 immunoreactivity was highly ated the extent of injury, as assessed by urinary protein
expressed in TAL and preglomerular arterioles, whereas excretion and reduced glomerular levels of inducible NO
its expression in the proximal tubules was much lower. synthase (iNOS) expression [34]. In the ischemia-reper-
On the other hand, HO-1 immunoreactivity was higher fusion model, the beneficial effect of HO-1 gene expres-
in the proximal tubules and was barely detectable in the sion was attributed to the antioxidant effects of bilirubin
arterioles or TAL under normal conditions. It is evident formed via heme degradation by HO-1 to biliverdin with
from these analyses, as well as from the antisense ODN subsequent conversion of biliverdin to bilirubin by bili-
experiments, that HO-2 is the renal constitutive HO verdin reductase [40]. In the model of glomerular im-
isoform and may serve as a key source for CO generation mune injury, the beneficial effect of HO-1 superinduc-
under normal conditions.
tion was attributed to reduced levels of iNOS owing toThe relatively high level of HO-2 protein in arterioles
degradation of its heme moiety by HO-1 [34]. In bothand TAL has important functional consequences. These
models of injury, CO was also implicated in attenuatingtwo tissues have been implicated as major sites of CO
the extent of injury via effects on renovascular tone andaction, the levels of which are primarily derived from
a down-regulatory effect on iNOS expression/activity.HO activity. Numerous studies have shown that CO is
Finally, in both models of injury, iNOS expression isgenerated in the vascular wall, specifically by smooth
increased and iNOS-derived NO may serve as a stimula-muscle [15, 16]. CO has been reported to play an impor-
tor of HO-1. Indeed, NO originating from NO donorstant role in the regulation of vascular tone [13]. Furchgott
or from iNOS activation by cytokines increases HO-1and Jothianandan and others have concluded that CO
expression in vascular smooth muscle cells [41] and inarising from heme via metabolism by HO exerts a vasodi-
mesangial cells [33]. Snyder and coworkers reported thatlatory effect and that inhibition of HO by tin mesopor-
an inhibitor of HO activity elicited vasodilation, whichphyrin causes vascular constriction [11, 35]. More re-
was prevented by the NOS inhibitor, L-NAME [42].cently, heme has been shown to elicit vasodilation in the
NOS is a heme dependent enzyme that can be inhibitedductus arteriosus [15] and inhibition of HO by chromium
by CO [43]. In addition, NO donors caused a noticeablemesoporphyrin resulted in elevation of arterial pressure
increase in the expression of HO-1 mRNA [41].[12]. Kozma et al showed that HO inhibitors magnify
In summary, our study demonstrates that HO-2 is amyogenic tone in the gracilis muscle arterioles and sug-
major contributor to endogenous HO activity under basalgested that endogenous HO-derived CO plays a role in
levels in the rat kidney. HO-1 becomes a major contribu-the regulation of basal tone in resistance vessels [14].
tor under pathological condition such as those that resultRecent studies using isoform-specific HO antisense oli-
gonucleotides demonstrated that HO-2–derived CO is in a release large amount of heme and hemoglobin, and
an inhibitory regulator of small renal artery reactivity to exposure to heavy metals. Differential localization of
phenylephrine, further emphasizing the potential role of HO-1 and HO-2 in renal tubular and vascular structure
HO isoforms in the regulation of renal hemodynamics is demonstrated, which suggest a different physiological
[36]. Thus, HO-2–derived CO may operate in concert role for the regulation of eicosanoid and CO production.
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